疤痕管理市场 - 全球产业规模、份额、趋势、机会及预测（按疤痕类型、产品、最终用途、地区和竞争格局划分，2021-2031年）

全球疤痕管理市场预计将从 2025 年的 17.1 亿美元成长到 2031 年的 22.7 亿美元，复合年增长率为 4.83%。

该市场涵盖多种治疗方案，包括注射、雷射治疗和外用硅胶贴片，旨在改善创伤、烧烫伤或手术造成的疤痕外观。推动这一市场成长的主要因素是皮肤损伤后美容和重组手术的增加，以及社会对外观日益增长的关注，这直接增加了对有效术后护理的需求。国际美容整形外科学会 (ISAPS) 的数据也支持这一趋势，该学会指出，疤痕修復术在 2024 年将成为全球五大美容外科手术之一。

儘管成长潜力巨大，但先进治疗方法的高昂费用却成为市场扩张的一大障碍。诸如手术修復和雷射治疗等高成本方案通常被归类为美容而非医疗，因此不包含在标准保险报销计划内。这种经济障碍限制了患者的就医途径，阻碍了高品质治疗方案的广泛应用，尤其是在对费用高度敏感的地区，高额的自付费用会抑制患者使用这些专业疗法。

市场驱动因素

烧烫伤和创伤病例的不断增加是市场成长的主要动力，也因此迫切需要有效的治疗性介入来解决外观畸形和功能障碍。严重烧伤通常会导致挛缩和增生性疤痕，持续推动全球对先进治疗方案（例如压力衣和硅胶片）的需求。美国国立卫生研究院 (NIH) 于 2025 年 8 月发布的题为《按地区和国家分類的全球烧伤负担》的研究报告凸显了这一医疗需求的规模。该研究估计全球严重烧伤患者人数高达 1,299 万，显示庞大的患者群体需要专门的局部用药製剂来优化伤口癒合和长期復健护理。

同时，消费者对恢復时间短、併发症发生率低的治疗方法的偏好，正推动着非侵入性和微创治疗方法的兴起，重塑着市场格局。这一趋势加速了注射和雷射治疗方法的普及，这些治疗方式无需进行修復手术即可有效改善疤痕。根据美国整形外科医师协会于2025年6月发布的《2024年手术统计报告》，2024年将进行超过370万例皮肤修復手术，显示非手术年轻化疗法正迅速普及。此外，皮肤疾病的持续高发也进一步扩大了潜在市场。正如美国皮肤病学会2025年指出的那样，痤疮每年影响多达5000万美国人，这显着增加了对萎缩性疤痕治疗的需求。

市场挑战

高昂的治疗方法费用和保险覆盖范围的不足是限制全球疤痕管理市场成长的重要因素。保险公司通常将高级治疗性介入，尤其是雷射治疗和手术修復，归类为美容项目而非医疗必需项目。这种分类使得这些项目无法获得标准报销，迫使患者自费承担昂贵的治疗费用。因此，高品质的疤痕管理方案主要局限于高收入人群，阻碍了市场惠及大量需要治疗但无力负担自费费用的患者群体。

这种经济壁垒造成了临床需求与市场可近性之间的巨大差距，有效地限制了医疗设备製造商和服务提供者的收入潜力。依赖患者自费支付阻碍了有效治疗方法的广泛应用，并将市场扩张主要限制在富裕的已开发国家。国际美容整形外科学会 (ISAPS) 的数据清楚地显示了这些成本对市场独占性的影响。该学会预测，到 2024 年，全球将进行约 1,156,446 例疤痕修復手术。虽然数量可观，但这仅占潜在市场的一小部分，因为高成本使得全球相当一部分遭受创伤或术后疤痕困扰的人群无法寻求专业治疗。

市场趋势

人工智慧驱动的疤痕评估技术的出现，正以客观、数据驱动的洞察取代主观评估，彻底改变临床决策。这些平台利用机器学习演算法分析伤口深度和癒合模式，使医疗专业人员能够针对复杂的皮肤疾病精准制定治疗方案，并在适当的时机进行干预。 Swift Medical 就是这数位转型的典型案例。该公司在 2024 年 1 月发布的资金筹措中宣布，已资金筹措800 万美元用于其人工智慧平台的开发。该平台利用超过 2000 万张伤口影像来优化临床评估。

同时，干细胞疗法与再生医学的融合标誌着疤痕治疗从被动管理转向主动生物修復。自体细胞采集等先进技术透过将前驱细胞直接输送到受损区域，促进天然皮肤结构的再生，从而最大限度地减少纤维化和挛缩的形成。这种方法也引起了商业性的广泛关注。根据Avita Medical于2024年11月发布的“2024年第三季财务业绩报告”，该公司再生医学技术RECELL的商业收入达到1950万美元，同比增长44%，这主要得益于其在皮肤修復领域的应用拓展。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球疤痕管理市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依瘢痕类型（萎缩性瘢痕、增生性/瘢痕疙瘩瘢痕、其他）
  • 细分产品（硅凝胶/喷雾、硅敷料、乳霜/软膏、其他）
  • 依申请方式（医院、门诊手术中心、其他）
  • 按地区
  • 按公司（2025 年）
• 市场地图

6. 北美疤痕管理市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲疤痕管理市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区疤痕管理市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲疤痕管理市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

10. 南美洲疤痕管理市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球疤痕管理市场：SWOT分析

第十四章 波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Advancis Medical
• Bayer AG
• B. Braun SE
• Bio Med Sciences, Inc.
• Covalon Technologies Ltd.
• Derma E
• MOlnlycke Health Care AB
• Newmedical Technology Inc.
• Quantum Health
• Smith & Nephew

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Scar Management Market is projected to expand from a valuation of USD 1.71 Billion in 2025 to reach USD 2.27 Billion by 2031, registering a compound annual growth rate of 4.83%. This market encompasses a diverse range of therapeutic solutions, including injectables, laser therapies, and topical silicone sheets, all aimed at improving the appearance of scars caused by trauma, burns, or surgeries. A key factor driving this growth is the rising volume of aesthetic and reconstructive surgeries necessitated by skin injuries and a growing societal emphasis on physical appearance, which directly increases the demand for effective post-operative care. This trend is substantiated by data from the International Society of Aesthetic Plastic Surgery (ISAPS), which identified scar revision as one of the top five surgical cosmetic procedures globally in 2024.

Despite this growth potential, market expansion is significantly hindered by the prohibitive costs associated with advanced treatment modalities. High-cost options such as surgical revisions and laser therapies are frequently categorized as cosmetic rather than medical, resulting in their exclusion from standard insurance reimbursement plans. This financial barrier restricts patient access and limits the widespread adoption of premium management solutions, particularly in cost-sensitive regions where high out-of-pocket expenses discourage the utilization of these specialized treatments.

Market Driver

The increasing prevalence of burns and traumatic injuries serves as a primary catalyst for market growth, creating an urgent need for robust therapeutic interventions to address aesthetic disfigurement and functional impairments. Severe thermal injuries often lead to contractures or hypertrophic scars, driving the sustained global demand for advanced management solutions such as pressure garments and silicone sheets. The scale of this medical necessity is highlighted by a National Institutes of Health study titled 'Global, Regional, and National Burden of Burn Injury' from August 2025, which estimated the global prevalence of severe burns at 12.99 million, thereby creating a substantial patient base requiring specialized topical formulations and extended post-acute care to optimize wound maturation.

Simultaneously, the market is being reshaped by a shift toward non-invasive and minimally invasive therapies, driven by consumer preference for procedures that offer reduced recovery times and lower complication rates. This trend has accelerated the adoption of injectable agents and laser-based modalities that provide effective scar remodeling without the invasiveness of surgical revision. According to the American Society of Plastic Surgeons' '2024 Procedural Statistics Report' released in June 2025, over 3.7 million skin resurfacing procedures were performed in 2024, reflecting the surging popularity of non-surgical rejuvenation. Additionally, the persistent burden of dermatological conditions further expands the addressable market; as noted by the American Academy of Dermatology in 2025, acne affects up to 50 million Americans annually, significantly contributing to the demand for atrophic scar treatments.

Market Challenge

The growth of the Global Scar Management Market is significantly hampered by the prohibitive costs of advanced treatment modalities and a widespread lack of insurance reimbursement. Insurance providers frequently classify advanced therapeutic interventions, particularly laser treatments and surgical revisions, as cosmetic rather than medically necessary. This classification leads to their exclusion from standard reimbursement schemes, forcing patients to bear the full financial burden of these expensive procedures. Consequently, the adoption of premium management solutions is largely restricted to individuals with higher disposable incomes, preventing the market from capitalizing on the vast number of patients who require treatment but cannot afford the out-of-pocket expenses.

This financial barrier creates a sharp divide between clinical need and market accessibility, effectively capping potential revenue for device manufacturers and service providers. The reliance on patient self-funding discourages the widespread utilization of effective therapies, limiting market expansion primarily to developed nations with wealthier patient demographics. The impact of these costs on market exclusivity is evident in data from the International Society of Aesthetic Plastic Surgery (ISAPS), which reported approximately 1,156,446 scar revision procedures globally in 2024; while substantial, this volume represents only a fraction of the total addressable market, as high costs deter a significant portion of the global population suffering from traumatic or post-surgical scars from seeking professional management.

Market Trends

The emergence of AI-driven scar assessment technologies is revolutionizing clinical decision-making by replacing subjective evaluations with objective, data-driven insights. These platforms utilize machine learning algorithms to analyze wound depth and healing patterns, enabling practitioners to tailor therapeutic regimens with precision and ensure timely interventions for complex dermatological conditions. This digital transformation is exemplified by Swift Medical, which, according to its January 2024 press release regarding a new financing round, secured $8 million to enhance its AI-powered platform that leverages over 20 million wound images to optimize clinical assessments.

Concurrently, the integration of stem cell therapies and regenerative medicine represents a shift from passive scar management to active biological repair. Advanced modalities, such as autologous cell harvesting, facilitate the regeneration of natural skin architecture by delivering progenitor cells directly to injury sites, thereby minimizing fibrosis and contracture formation. This approach is gaining significant commercial traction, as evidenced by Avita Medical's 'Third Quarter 2024 Financial Results' from November 2024, which reported that commercial revenue for its regenerative RECELL technology reached $19.5 million, marking a 44% increase compared to the previous year due to expanded usage in skin restoration.

Key Market Players

• Advancis Medical
• Bayer AG
• B. Braun S.E.
• Bio Med Sciences, Inc.
• Covalon Technologies Ltd.
• Derma E
• MOlnlycke Health Care AB
• Newmedical Technology Inc.
• Quantum Health
• Smith & Nephew

Report Scope

In this report, the Global Scar Management Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Scar Management Market, By Scar Type

• Atrophic Scars
• Hypertrophic and Keloid Scars
• Others

Scar Management Market, By Product

• Silicone Gel and Spray
• Silicon Dressing
• Cream and Ointment
• Others

Scar Management Market, By End-use

• Hospitals
• Ambulatory Surgical Centers
• Others

Scar Management Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Scar Management Market.

Available Customizations:

Global Scar Management Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Scar Management Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Scar Type (Atrophic Scars, Hypertrophic and Keloid Scars, Others)
  • 5.2.2. By Product (Silicone Gel and Spray, Silicon Dressing, Cream and Ointment, Others)
  • 5.2.3. By End-use (Hospitals, Ambulatory Surgical Centers, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Scar Management Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Scar Type
  • 6.2.2. By Product
  • 6.2.3. By End-use
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Scar Management Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Scar Type
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By End-use
  • 6.3.2. Canada Scar Management Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Scar Type
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By End-use
  • 6.3.3. Mexico Scar Management Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Scar Type
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By End-use

7. Europe Scar Management Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Scar Type
  • 7.2.2. By Product
  • 7.2.3. By End-use
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Scar Management Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Scar Type
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By End-use
  • 7.3.2. France Scar Management Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Scar Type
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By End-use
  • 7.3.3. United Kingdom Scar Management Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Scar Type
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By End-use
  • 7.3.4. Italy Scar Management Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Scar Type
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By End-use
  • 7.3.5. Spain Scar Management Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Scar Type
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By End-use

8. Asia Pacific Scar Management Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Scar Type
  • 8.2.2. By Product
  • 8.2.3. By End-use
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Scar Management Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Scar Type
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By End-use
  • 8.3.2. India Scar Management Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Scar Type
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By End-use
  • 8.3.3. Japan Scar Management Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Scar Type
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By End-use
  • 8.3.4. South Korea Scar Management Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Scar Type
      • 8.3.4.2.2. By Product
      • 8.3.4.2.3. By End-use
  • 8.3.5. Australia Scar Management Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Scar Type
      • 8.3.5.2.2. By Product
      • 8.3.5.2.3. By End-use

9. Middle East & Africa Scar Management Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Scar Type
  • 9.2.2. By Product
  • 9.2.3. By End-use
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Scar Management Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Scar Type
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By End-use
  • 9.3.2. UAE Scar Management Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Scar Type
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By End-use
  • 9.3.3. South Africa Scar Management Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Scar Type
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By End-use

10. South America Scar Management Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Scar Type
  • 10.2.2. By Product
  • 10.2.3. By End-use
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Scar Management Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Scar Type
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By End-use
  • 10.3.2. Colombia Scar Management Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Scar Type
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By End-use
  • 10.3.3. Argentina Scar Management Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Scar Type
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By End-use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Scar Management Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Advancis Medical
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Bayer AG
• 15.3. B. Braun S.E.
• 15.4. Bio Med Sciences, Inc.
• 15.5. Covalon Technologies Ltd.
• 15.6. Derma E
• 15.7. MOlnlycke Health Care AB
• 15.8. Newmedical Technology Inc.
• 15.9. Quantum Health
• 15.10. Smith & Nephew

16. Strategic Recommendations

17. About Us & Disclaimer